Crisil Ratings reports that President Trump's order to cut US drug prices will have a limited effect on Indian pharma.

Citing the reason behind its observation, the credit rating firm in its report said that despite India exporting over half of ...

The prefilled syringe drug molecule market has seen significant evolution as healthcare systems globally strive for safer, more efficient drug delivery methods. Prefilled syringes offer an innovative ...

I've always wanted to differentiate; I never wanted to be a me-too. I always want to lead, not follow,' says Executive ...

This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing. IMforte [NCT05091567] is a Phase III, open-label, randomized trial evaluating the ...

The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...

Biosimilar associations advocate for lower development costs and streamlined regulations to enhance patient access to ...

Oncology biosimilars significantly reduce financial toxicity in cancer care, as highlighted in 2 abstracts presented at the ...

Swiss generic and biosimilar medicines company Sandoz (SWX: SDZ) today announced that Wyost (denosumab) and Jubbonti ...

In a website posting, the International Generic and Biosimilar medicines Association (IGBA) has commended the General ...

The FDA has approved Starjemza (ustekinumab-hmny), a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

The Pharma world is seeing a big opportunity in GLP-1s – the new innovative fast emerging drugs for diabetes & obesity. Kiran ...